China Generics Market Set To Reach $82 Billion As Local Makers Lag
This article was originally published in PharmAsia News
Executive Summary
China's limitations in industrial development and technology when it comes to making generic copies of drugs facing loss of patent protection could cost it an opportunity to cash in on its own $81.7 billion market expected by 2015.